Showing results (411-420 of 570) with videos related to

Sort By:
Pageof 57
JAMA Internal Medicine|February 28, 2022
Mindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical TrialEric L Garland, Adam W Hanley, Yoshio Nakamura, et al.
Infectious Agents and Cancer|February 16, 2021
Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosisSteven F Gameiro, Farhad Ghasemi, Peter Y F Zeng, et al.
Animal Reproduction Science|May 5, 2007
Effects of treatment with GnRH from 4 to 8 weeks of age on the attainment of sexual maturity in bull calvesS Madgwick, E T Bagu, R Duggavathi, et al.
Analytical Biochemistry|July 15, 1997
A generic method for the production of cell lines expressing high levels of 7-transmembrane receptorsK J Koller, E A Whitehorn, E Tate, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 17, 2014
Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancerSung Ho Um, Neil Mundi, John Yoo, et al.
Cureus|March 7, 2024
Personalized Treatment of Recurrent, Metastatic Head and Neck Cancer Guided by Patient-Derived Xenograft ModelsMorgan D Black, John Yoo, Kevin Fung, et al.
Journal of Cardiology|August 9, 2011
Atrial fibrillation and flutter outcomes and risk determination (AFFORD): design and rationaleTyler W Barrett, Alan B Storrow, Cathy A Jenkins, et al.
Molecular Therapy Oncolytics|April 28, 2016
Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasisJessica G Tong, Yudith Ramos Valdes, John W Barrett, et al.
Bio/Technology (Nature Publishing Company)|November 1, 1995
A generic method for expression and use of "tagged" soluble versions of cell surface receptorsE A Whitehorn, E Tate, S D Yanofsky, et al.
Molecular Pharmacology|December 1, 1989
Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33)C W Lin, M W Holladay, R W Barrett, et al.
Pageof 57